Back to results
US 5,492,892 AGranted
Endothelin antagonists
OwnerThomas T. Andersen, Michael J. Spinellainventors
Life of this patent
Estimating the term…
Abstract
The present invention as directed to a compound which comprises an endothelin antagonist polypeptide that is at least 40% homologous to an endothelin active peptide, consisting of Et-1, Et-2, Et-3, SC, SA and SB and has the formula: ##STR1## and pharmaceutically acceptable salts.
Claims15
A compound selected from the group consisting of:
- ##STR53##
Dependencies are inferred from the claim text.